161 related articles for article (PubMed ID: 21535387)
21. High-resolution epitope mapping by HX MS reveals the pathogenic mechanism and a possible therapy for autoimmune TTP syndrome.
Casina VC; Hu W; Mao JH; Lu RN; Hanby HA; Pickens B; Kan ZY; Lim WK; Mayne L; Ostertag EM; Kacir S; Siegel DL; Englander SW; Zheng XL
Proc Natl Acad Sci U S A; 2015 Aug; 112(31):9620-5. PubMed ID: 26203127
[TBL] [Abstract][Full Text] [Related]
22. Amino acid regions 572-579 and 657-666 of the spacer domain of ADAMTS13 provide a common antigenic core required for binding of antibodies in patients with acquired TTP.
Luken BM; Turenhout EA; Kaijen PH; Greuter MJ; Pos W; van Mourik JA; Fijnheer R; Voorberg J
Thromb Haemost; 2006 Sep; 96(3):295-301. PubMed ID: 16953270
[TBL] [Abstract][Full Text] [Related]
23. Persistence of circulating ADAMTS13-specific immune complexes in patients with acquired thrombotic thrombocytopenic purpura.
Ferrari S; Palavra K; Gruber B; Kremer Hovinga JA; Knöbl P; Caron C; Cromwell C; Aledort L; Plaimauer B; Turecek PL; Rottensteiner H; Scheiflinger F
Haematologica; 2014 Apr; 99(4):779-87. PubMed ID: 24241492
[TBL] [Abstract][Full Text] [Related]
24. Potential for Recombinant ADAMTS13 as an Effective Therapy for Acquired Thrombotic Thrombocytopenic Purpura.
Tersteeg C; Schiviz A; De Meyer SF; Plaimauer B; Scheiflinger F; Rottensteiner H; Vanhoorelbeke K
Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2336-42. PubMed ID: 26338302
[TBL] [Abstract][Full Text] [Related]
25. Thrombotic thrombocytopenic purpura and other thrombotic microangiopathic hemolytic anemias: diagnosis and classification.
Shenkman B; Einav Y
Autoimmun Rev; 2014; 13(4-5):584-6. PubMed ID: 24418304
[TBL] [Abstract][Full Text] [Related]
26. Epitope mapping of ADAMTS13 autoantibodies in acquired thrombotic thrombocytopenic purpura.
Klaus C; Plaimauer B; Studt JD; Dorner F; Lämmle B; Mannucci PM; Scheiflinger F
Blood; 2004 Jun; 103(12):4514-9. PubMed ID: 14976043
[TBL] [Abstract][Full Text] [Related]
27. ADAMTS13 conformations and mechanism of inhibition in immune thrombotic thrombocytopenic purpura.
Halkidis K; Zheng XL
J Thromb Haemost; 2022 Oct; 20(10):2197-2203. PubMed ID: 35842925
[TBL] [Abstract][Full Text] [Related]
28. Unraveling the immunologic response in thrombotic thrombocytopenic purpura.
Knöbl P
J Thromb Haemost; 2006 Nov; 4(11):2352-4. PubMed ID: 16938122
[No Abstract] [Full Text] [Related]
29. Ribosomal and immune transcripts associate with relapse in acquired ADAMTS13-deficient thrombotic thrombocytopenic purpura.
Edgar CE; Terrell DR; Vesely SK; Wren JD; Dozmorov IM; Niewold TB; Brown M; Zhou F; Frank MB; Merrill JT; Kremer Hovinga JA; Lämmle B; James JA; George JN; Farris AD
PLoS One; 2015; 10(2):e0117614. PubMed ID: 25671313
[TBL] [Abstract][Full Text] [Related]
30. IgG subclass distribution of anti-ADAMTS13 antibodies in patients with acquired thrombotic thrombocytopenic purpura.
Ferrari S; Mudde GC; Rieger M; Veyradier A; Kremer Hovinga JA; Scheiflinger F
J Thromb Haemost; 2009 Oct; 7(10):1703-10. PubMed ID: 19682238
[TBL] [Abstract][Full Text] [Related]
31. [Thrombotic Thrombocytopenic Purpura --Pathophysiology and Assays of ADAMTS13 Activity].
Kato S; Fujimura Y
Rinsho Byori; 2015 Oct; 63(10):1228-36. PubMed ID: 26897861
[TBL] [Abstract][Full Text] [Related]
32. Acquired thrombotic thrombocytopenic purpura: ADAMTS13 activity, anti-ADAMTS13 autoantibodies and risk of recurrent disease.
Lämmle B; Kremer Hovinga JA; George JN
Haematologica; 2008 Feb; 93(2):172-7. PubMed ID: 18245649
[No Abstract] [Full Text] [Related]
33. Rituximab as pre-emptive treatment in patients with thrombotic thrombocytopenic purpura and evidence of anti-ADAMTS13 autoantibodies.
Bresin E; Gastoldi S; Daina E; Belotti D; Pogliani E; Perseghin P; Scalzulli PR; Paolini R; Marcenò R; Remuzzi G; Galbusera M
Thromb Haemost; 2009 Feb; 101(2):233-8. PubMed ID: 19190804
[TBL] [Abstract][Full Text] [Related]
34. ADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpura.
Zheng XL
Annu Rev Med; 2015; 66():211-25. PubMed ID: 25587650
[TBL] [Abstract][Full Text] [Related]
35. ADAMTS13-binding IgG are present in patients with thrombotic thrombocytopenic purpura.
Tsai HM; Raoufi M; Zhou W; Guinto E; Grafos N; Ranzurmal S; Greenfield RS; Rand JH
Thromb Haemost; 2006 May; 95(5):886-92. PubMed ID: 16676082
[TBL] [Abstract][Full Text] [Related]
36. ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases.
Rieger M; Mannucci PM; Kremer Hovinga JA; Herzog A; Gerstenbauer G; Konetschny C; Zimmermann K; Scharrer I; Peyvandi F; Galbusera M; Remuzzi G; Böhm M; Plaimauer B; Lämmle B; Scheiflinger F
Blood; 2005 Aug; 106(4):1262-7. PubMed ID: 15890682
[TBL] [Abstract][Full Text] [Related]
37. ADAMTS13 and von Willebrand factor interactions.
Zander CB; Cao W; Zheng XL
Curr Opin Hematol; 2015 Sep; 22(5):452-9. PubMed ID: 26186678
[TBL] [Abstract][Full Text] [Related]
38. Familial acquired thrombotic thrombocytopenic purpura: ADAMTS13 inhibitory autoantibodies in identical twins.
Studt JD; Kremer Hovinga JA; Radonic R; Gasparovic V; Ivanovic D; Merkler M; Wirthmueller U; Dahinden C; Furlan M; Lämmle B
Blood; 2004 Jun; 103(11):4195-7. PubMed ID: 14982879
[TBL] [Abstract][Full Text] [Related]
39. The clinical utility of ADAMTS13 activity, antigen and autoantibody assays in thrombotic thrombocytopenic purpura.
Starke R; Machin S; Scully M; Purdy G; Mackie I
Br J Haematol; 2007 Feb; 136(4):649-55. PubMed ID: 17367414
[TBL] [Abstract][Full Text] [Related]
40. Anti-ADAMTS13 Autoantibodies against Cryptic Epitopes in Immune-Mediated Thrombotic Thrombocytopenic Purpura.
Roose E; Vidarsson G; Kangro K; Verhagen OJHM; Mancini I; Desender L; Pareyn I; Vandeputte N; Vandenbulcke A; Vendramin C; Schelpe AS; Voorberg J; Azerad MA; Gilardin L; Scully M; Dierickx D; Deckmyn H; De Meyer SF; Peyvandi F; Vanhoorelbeke K
Thromb Haemost; 2018 Oct; 118(10):1729-1742. PubMed ID: 30235483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]